Company

Freedom to discover

We are developing a flexible, accessible platform to accelerate single-cell, functional analysis at scale. By consolidating multiple, complex assays into intuitive streamlined workflows we are addressing key limitations in existing methods to provide the freedom to innovate and discover across a broad range of disciplines, from basic and translational research to drug discovery.

Company

Freedom to discover

We are developing a flexible, accessible platform to accelerate single-cell, functional analysis at scale. By consolidating multiple, complex assays into intuitive streamlined workflows we are addressing key limitations in existing methods to provide the freedom to innovate and discover across a broad range of disciplines, from basic and translational research to drug discovery.

Latest News

Meet our team

Leadership team

Our leadership team builds on extensive experience across biology, chemistry, physics, engineering, cell biology, single cell, and genomics.

Paul Loeffen
CEO
Craig Tombling
COO
Paul Steinberg
CCO
Justine Brain
VP Finance
Heidi McQueen
Director of People
Kathrin Herbst
Director of Science and Business Development
Matthew Wright
Director of Software and Integration
Roger Haley
Director of IP and Legal
Scott Brouilette
Director of Marketing
Simon Margerison
Director of Application Support
Tom Isaac
Director of Microfluidic Products
No items found.

Our advisors

Our advisors

No items found.
Clare Bryant
University of Cambridge
Professor of Innate Immunity

Our investors

Latest News

We’re hiring. Join the cast!

We are building an amazing team where talented people (like you) can come together to build great things.

Register to receive updates

Be the first to know about product news and events.

Register to receive updates

Be the first to know about product news and events.